Good morning. My name is Chelsea, and I will be your conference operator today. At this time, I would like to welcome everyone to the Pangaea Logistics Solutions Fourth Quarter and Full Year 2025 ...

Immunome is advancing varegacestat for desmoid tumors, targeting NDA submission in Q2 2026 after positive phase 3 RINGSIDE ...

FY25 EPS of $0.08; FY25 Adjusted EPS growth of 5% to $0.83YoY Increase in Cash Flow from Operations of $148 million; ...